Articles Tagged With: naloxone
-
Feds Greenlight Expanded Naloxone Availability
The FDA has approved the nasal spray version of the opioid overdose reversal agent for over-the-counter sales.
-
Case Managers Can Better Educate Patients and Families About Opioid Addiction
While the world focused on the COVID-19 pandemic, another crisis — the opioid epidemic — continued to unfold, taking hundreds of thousands of lives. Hospital discharge is an opportunity for case managers and other providers to help prevent patients from becoming victims of opioid overdoses.
-
AMA Asks to Remove Prescription Status from Naloxone
The request was made in the wake of a study that revealed expanded access to the opioid reversal agent is needed in almost every U.S. state.
-
Unexpected Gaps in Opioid Overdose Treatments
Patients presenting to EDs for opioid overdose should go home with a naloxone prescription or a naloxone take-home kit. Alternatively, these patients could start buprenorphine when it is clinically feasible, or they could be connected directly to outpatient treatment for opioid use disorder.
-
Researchers: Emergency Providers Missing Chances to Avert Future Opioid Disasters
Investigators express concern about prescribing rates for medication-assisted treatment after ED visits for opioid overdoses recorded between late 2019 and early 2021.
-
Legal Exposure for ED When Overdose Patients Refuse Care
One concern is that whatever the patient overdosed on, which often is unknown, will outlast the duration of the reversal agent.
-
Busting Myths About Naloxone
FDA attempts to clear up some common misconceptions about the opioid overdose-reversing treatment.
-
Annual Survey Reveals Mixed Findings on U.S. Mental Health, Substance Use
Illicit drug use among young Americans declined slightly, but too many people are not seeking proper treatment for various disorders.
-
Advanced Management of Opioid Overdose in the Emergency Department
This article aims to provide acute care providers with advanced techniques in the management of opioid overdoses, including the use of naloxone, the opioid receptor antagonist, as well as harm reduction management strategies aimed at long-term risk mitigation in this vulnerable population.